Clinical Support Tool for Preventing Cognitive Decline
(PCOT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether a new tool, the Clinical Support Decision Tool, can help doctors manage high blood pressure more effectively to potentially prevent memory problems like dementia. Participants will either receive usual care or use a decision support tool that shares blood pressure data with doctors to guide treatment. The trial seeks individuals aged 70 or older who have high blood pressure, have recently visited a primary care doctor, and own a smartphone.
As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance future healthcare practices.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this Clinical Support Decision Tool is safe for preventing cognitive decline?
Research has shown that clinical decision support tools are generally safe and easy to use. These tools assist doctors in making better decisions by utilizing up-to-date information and electronic health records. Studies have found that they can improve treatment accuracy and reduce delays without harming patients. Although specific safety data for this tool is limited, its use in healthcare has not been linked to any major problems. The tool in this trial aims to better manage blood pressure, which should safely lower the risk of cognitive decline.12345
Why are researchers excited about this trial?
Researchers are excited about the Clinical Support Decision (CDS) tool for preventing cognitive decline because it offers a more personalized approach to managing blood pressure, a key factor in cognitive health. Unlike standard care, which relies on physicians making treatment decisions based on periodic office visits, this tool uses real-time home blood pressure data sent via smartphone apps. This continuous monitoring allows for more timely adjustments in blood pressure management, potentially reducing the risk of cognitive decline associated with hypertension. By integrating technology into routine care, the CDS tool empowers physicians with data-driven insights, potentially leading to better patient outcomes.
What evidence suggests that the Clinical Support Decision Tool is effective for preventing cognitive decline?
Studies have shown that tools designed to assist doctors in decision-making can improve health outcomes. In this trial, participants in the intervention arm will use a Clinical Decision Support (CDS) tool to manage high blood pressure. These tools use real-time data to help doctors adjust treatment plans effectively. Research indicates that using these tools can lead to better blood pressure control, which is linked to a lower risk of memory and thinking problems, such as mild cognitive impairment and dementia. In some cases, these tools have made treatment recommendations more accurate and efficient. Although specific data on preventing memory decline with this tool is limited, the link between managing blood pressure and brain health suggests potential benefits. Participants in the usual care arm will continue with their standard hypertension management without the CDS tool.13456
Are You a Good Fit for This Trial?
This trial is for people aged 70 or older with high blood pressure, defined as two readings of SBP >= 130 or DBP >=80 in the last 24 months. Participants must be able to communicate in English or Spanish, have visited a primary care provider within the last two years, and own a smartphone or tablet.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive intensive blood pressure management with clinical decision support and team-based care
Follow-up
Participants are monitored for safety and effectiveness after treatment
Quality of Life Assessment
Quality of life scores are assessed annually using the PROMIS Scale v1.2 - Global Health instrument
What Are the Treatments Tested in This Trial?
Interventions
- Clinical Support Decision Tool
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas Southwestern Medical Center
Lead Sponsor
Duke University
Collaborator
National Institute on Aging (NIA)
Collaborator
Parkland Health and Hospital System
Collaborator